Rifampin Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-351

4 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Rifampin (NDC 63323-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rif01 0002 01

Rif01 0002 01
Chemical structure of the active ingredient rifampin. The structure displays the molecular formula C43H58N4O12 with a molecular weight of 822.95.*
FDA Label Image

Rif01 0002 02

FDA Label Image

Rif01 0002 03

Rif01 0002 03
Rifampin for Injection, USP vial label showing 600 mg per vial strength. This is an intravenous lyophilized powder injection by Fresenius Kabi USA, LLC. The label includes reconstitution instructions, storage conditions, and states the product is for intravenous infusion only. The NDC 63323-351 is displayed along with a barcode.*
FDA Label Image

Rif01 0002 04

Rif01 0002 04
Label for Rifampin for Injection, USP 600 mg per vial. The product is indicated for intravenous infusion only. The label includes the NDC 63323-351-20 and states it is provided as one sterile vial. The labeler is Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.